Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus in Chronic Allograft Nephropathy
NCT00282217Phase 4Completed
- Sponsor
- Pfizer
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in Chronic Allograft Kidney Disease (CKaD), sponsored by Pfizer. Primary endpoint: Renal function at 12 months (Slope of GFR). Started Aug 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
Chronic Allograft Kidney Disease (CKaD)
Beyond the preview
Go deeper on NCT00282217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00282217.